Notably, c-MYC is commonly overexpressed in several haematological malignancies, such as Burkitt lymphoma (BL), a B cell malignancy driven by the t(8;14) chromosomal translocation that subjugates the c-MYC gene under the control of the immunoglobulin heavy (IgH) chain gene enhancer Eμ [3]. Here, MYC is linked to Burkitt lymphoma.